AI software developer iCAD has announced the appointment of Mark Koeniguer as its new chief commercial officer (CCO).
In the CCO role, Koeniguer will be responsible for commercial sales teams, partnerships, and operations for both North America and globally, the Nashua, NH-based iCAD said in a statement.
Koeniguer has previously served as CEO of ScreenPoint Medical; he has also held executive leadership roles at Riverain Technologies, Volpara Health, R2 Technology, Stereotaxis, and GE Healthcare.
iCAD is the developer of the AI-enabled mammography analysis ProFound Breast Health Suite for breast cancer detection, density assessment, and risk evaluation.
Leave a Reply